Loading clinical trials...
Loading clinical trials...
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder - OBOE-Mayo
Conditions
Interventions
Group Therapy Program
semaglutide
+2 more
Locations
1
United States
Mayo Clinic
Rochester, Minnesota, United States
Start Date
January 19, 2026
Primary Completion Date
February 1, 2028
Completion Date
February 1, 2029
Last Updated
March 11, 2026
NCT07172516
NCT06184581
NCT06804525
NCT05303064
NCT05837104
NCT05343598
Lead Sponsor
Mayo Clinic
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions